LEADER 01161nam0-22004091i-450-
001 990006133250403321
005 20150701112803.0
035   $a000613325
035   $aFED01000613325
035   $a(Aleph)000613325FED01
035   $a000613325
100   $a20130719d1993----km-y0itay50------ba
101 0 $aita
102   $aIT
105   $a--------00-yy
200 1 $a<<La >>rescissione del contratto di appalto di opere pubbliche$eautotutela e potere negoziale della pubblica amministrazione$fFelice Ancora
210   $aMilano$cGiuffrè$d1993
215   $aVI, 165 p.$d24 cm
676   $a350.711
676   $a342
676   $a346.02
700  1$aAncora,$bFelice$0232960
801  0$aIT$bUNINA$gRICA$2UNIMARC
901   $aBK
912   $a990006133250403321
952   $aDP XXIX - 148$b12696$fDEC
952   $aVIII F 890$b21668*$fFGBC
952   $aDPR 15-260$b12265$fDEC
952   $aD-53$b1311 dip.$fDDRC
952   $a16-C-23$b5433$fDDCP
959   $aDEC
959   $aFGBC
959   $aDEC
959   $aDDRC
959   $aDDCP
996   $aRescissione del contratto di appalto di opere pubbliche$9643278
997   $aUNINA

LEADER 01256nas  2200433-  450 
001 996321133003316
005 20210920213022.0
011   $a2318-9312
035   $a(OCoLC)952999556
035   $a(CKB)110978978189530
035   $a(CONSER)--2017268652
035   $a(EXLCZ)99110978978189530
100   $a19981016a19929999  ---            a
101 0 $apor
135   $aur|n|||||||||
181   $ctxt$2rdacontent
182   $cc$2rdamedia
183   $acr$2rdacarrier
200 00$aInfarma
210  1$aBrasília :$cConselho Federal de Farmácia,$d1992-
215   $a1 online resource
300   $aRefereed/Peer-reviewed
311   $a0104-0219 
517 1 $aCiências farmacêuticas
531 1 $aInfarma
606   $aPharmacy$xResearch$vPeriodicals
606   $aDrugs$xResearch$vPeriodicals
606   $aDrugs$xResearch$2fast$3(OCoLC)fst00898894
606   $aPharmacy$xResearch$2fast$3(OCoLC)fst01060314
608   $aPeriodicals.$2fast
615  0$aPharmacy$xResearch
615  0$aDrugs$xResearch
615  7$aDrugs$xResearch.
615  7$aPharmacy$xResearch.
712 02$aConselho Federal de Farmácia (Brazil),
906   $aJOURNAL
912   $a996321133003316
996   $aInfarma$92578211
997   $aUNISA